Literature DB >> 28911965

Physiological roles of CNS muscarinic receptors gained from knockout mice.

Morgane Thomsen1, Gunnar Sørensen2, Ditte Dencker3.   

Abstract

Because the five muscarinic acetylcholine receptor subtypes have overlapping distributions in many CNS tissues, and because ligands with a high degree of selectivity for a given subtype long remained elusive, it has been difficult to determine the physiological functions of each receptor. Genetically engineered knockout mice, in which one or more muscarinic acetylcholine receptor subtype has been inactivated, have been instrumental in identifying muscarinic receptor functions in the CNS, at the neuronal, circuit, and behavioral level. These studies revealed important functions of muscarinic receptors modulating neuronal activity and neurotransmitter release in many brain regions, shaping neuronal plasticity, and affecting functions ranging from motor and sensory function to cognitive processes. As gene targeting technology evolves including the use of conditional, cell type specific strains, knockout mice are likely to continue to provide valuable insights into brain physiology and pathophysiology, and advance the development of new medications for a range of conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia, and addictions, as well as non-opioid analgesics. This article is part of the Special Issue entitled 'Neuropharmacology on Muscarinic Receptors'.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholinergic; Knock-out; Knockout; Mice; Muscarinic; Null mutation

Mesh:

Substances:

Year:  2017        PMID: 28911965      PMCID: PMC5845799          DOI: 10.1016/j.neuropharm.2017.09.011

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  144 in total

1.  Presynaptic muscarinic M(2) receptors modulate glutamatergic transmission in the bed nucleus of the stria terminalis.

Authors:  Ji-Dong Guo; Rimi Hazra; Joanna Dabrowska; E Chris Muly; Jürgen Wess; Donald G Rainnie
Journal:  Neuropharmacology       Date:  2011-12-08       Impact factor: 5.250

2.  M2 muscarinic acetylcholine receptors regulate long-term potentiation at hippocampal CA3 pyramidal cell synapses in an input-specific fashion.

Authors:  Fang Zheng; Jürgen Wess; Christian Alzheimer
Journal:  J Neurophysiol       Date:  2012-04-04       Impact factor: 2.714

3.  Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.

Authors:  Morgane Thomsen; Simon Barak Caine
Journal:  Eur J Pharmacol       Date:  2016-02-11       Impact factor: 4.432

4.  Decreased input-specific plasticity of the auditory cortex in mice lacking M1 muscarinic acetylcholine receptors.

Authors:  Yunfeng Zhang; Susan E Hamilton; Neil M Nathanson; Jun Yan
Journal:  Cereb Cortex       Date:  2005-11-16       Impact factor: 5.357

5.  Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline.

Authors:  Rodrigo Medeiros; Masashi Kitazawa; Antonella Caccamo; David Baglietto-Vargas; Tatiana Estrada-Hernandez; David H Cribbs; Avraham Fisher; Frank M LaFerla
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

6.  Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.

Authors:  Sarah Threlfell; Michael A Clements; Tansi Khodai; Ilse S Pienaar; Richard Exley; Jürgen Wess; Stephanie J Cragg
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

7.  Presynaptic m1 muscarinic receptors are necessary for mGluR long-term depression in the hippocampus.

Authors:  Ariel Kamsler; Thomas J McHugh; David Gerber; Shu Ying Huang; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

8.  Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.

Authors:  Daniel J Foster; Jermaine M Wilson; Daniel H Remke; M Suhaib Mahmood; M Jashim Uddin; Jürgen Wess; Sachin Patel; Lawrence J Marnett; Colleen M Niswender; Carrie K Jones; Zixiu Xiang; Craig W Lindsley; Jerri M Rook; P Jeffrey Conn
Journal:  Neuron       Date:  2016-09-08       Impact factor: 17.173

9.  Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice.

Authors:  Alokesh Duttaroy; Jesus Gomeza; Jai-Wei Gan; Nasir Siddiqui; Anthony S Basile; W Dean Harman; Philip L Smith; Christian C Felder; Allan I Levey; Jürgen Wess
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

10.  Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.

Authors:  Michael Bubser; Thomas M Bridges; Ditte Dencker; Robert W Gould; Michael Grannan; Meredith J Noetzel; Atin Lamsal; Colleen M Niswender; J Scott Daniels; Michael S Poslusney; Bruce J Melancon; James C Tarr; Frank W Byers; Jürgen Wess; Mark E Duggan; John Dunlop; Michael W Wood; Nicholas J Brandon; Michael R Wood; Craig W Lindsley; P Jeffrey Conn; Carrie K Jones
Journal:  ACS Chem Neurosci       Date:  2014-08-19       Impact factor: 4.418

View more
  14 in total

1.  Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes.

Authors:  Shoji Maeda; Qianhui Qu; Michael J Robertson; Georgios Skiniotis; Brian K Kobilka
Journal:  Science       Date:  2019-05-10       Impact factor: 47.728

2.  Examining the role of muscarinic M5 receptors in VTA cholinergic modulation of depressive-like and anxiety-related behaviors in rats.

Authors:  Eric J Nunes; Laura E Rupprecht; Daniel J Foster; Craig W Lindsley; P Jeffrey Conn; Nii A Addy
Journal:  Neuropharmacology       Date:  2020-04-05       Impact factor: 5.250

3.  Protective effect of fisetin against subchronic chlorpyrifos-induced toxicity on oxidative stress biomarkers and neurobehavioral parameters in adult male albino mice.

Authors:  Amaka Rosita Akpa; Joseph Olusegun Ayo; Hudu Garba Mika'il; Friday Ocheja Zakari
Journal:  Toxicol Res       Date:  2020-07-07

Review 4.  The retrotrapezoid nucleus and the neuromodulation of breathing.

Authors:  Thiago S Moreira; Cleyton R Sobrinho; Barbara Falquetto; Luiz M Oliveira; Janayna D Lima; Daniel K Mulkey; Ana C Takakura
Journal:  J Neurophysiol       Date:  2020-12-02       Impact factor: 2.714

5.  Autoradiography of 3H-pirenzepine and 3H-AFDX-384 in Mouse Brain Regions: Possible Insights into M1, M2, and M4 Muscarinic Receptors Distribution.

Authors:  Paulina Valuskova; Vladimir Farar; Sandor Forczek; Iva Krizova; Jaromir Myslivecek
Journal:  Front Pharmacol       Date:  2018-02-20       Impact factor: 5.810

6.  Impaired object-location learning and recognition memory but enhanced sustained attention in M2 muscarinic receptor-deficient mice.

Authors:  Carola Romberg; Susan Bartko; Jürgen Wess; Lisa M Saksida; Timothy J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2018-10-16       Impact factor: 4.530

Review 7.  The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease.

Authors:  Rola A Bekdash
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

8.  Excitatory-inhibitory tone shapes decision strategies in a hierarchical neural network model of multi-attribute choice.

Authors:  Warren Woodrich Pettine; Kenway Louie; John D Murray; Xiao-Jing Wang
Journal:  PLoS Comput Biol       Date:  2021-03-11       Impact factor: 4.475

9.  Dynamic monitoring of single-terminal norepinephrine transporter rate in the rodent cardiovascular system: A novel fluorescence imaging method.

Authors:  Lily L Cao; Andrew P Holmes; Janice M Marshall; Larissa Fabritz; Keith L Brain
Journal:  Auton Neurosci       Date:  2019-12-26       Impact factor: 3.145

10.  Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus.

Authors:  Fabio Del Bello; Alessandro Bonifazi; Gianfabio Giorgioni; Alessandro Piergentili; Maria Giovanna Sabbieti; Dimitrios Agas; Marzia Dell'Aera; Rosanna Matucci; Marcin Górecki; Gennaro Pescitelli; Giulio Vistoli; Wilma Quaglia
Journal:  J Med Chem       Date:  2020-05-19       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.